tirzepatide patent status In weight loss battle, Novo and Lilly face growing offensive from licensed copies In weight loss battle, Novo

Learn about fatigue as a potential side effect of tirzepatide, how common it is, what causes tiredness during treatment, and practical strategies to manage energy levels while taking this weight management medication.

Up to 40% of weight lost on semaglutide may be lean mass

Healio previously reported results from the FLOW trial, which found the GLP-1 semaglutide 1 mg (Ozempic, Novo Nordisk) significantly decreased risks for major kidney disease events,

Learn about UHC prior authorization requirements, step therapy rules, and how to get coverage approved fast.

Learn more about our customized employee benefit plans.